These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12457280)

  • 61. Generation of albino Xenopus tropicalis using zinc-finger nucleases.
    Nakajima K; Nakajima T; Takase M; Yaoita Y
    Dev Growth Differ; 2012 Dec; 54(9):777-84. PubMed ID: 23106502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular basis of mouse Himalayan mutation.
    Kwon BS; Halaban R; Chintamaneni C
    Biochem Biophys Res Commun; 1989 May; 161(1):252-60. PubMed ID: 2567165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted sequence alteration of a chromosomal locus in mouse liver.
    Kamiya H; Uchiyama M; Piao J; Nakatsu Y; Tsuzuki T; Harashima H
    Int J Pharm; 2010 Mar; 387(1-2):180-3. PubMed ID: 20025952
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy.
    Liu CM; Liu DP; Liang CC
    J Mol Med (Berl); 2002 Oct; 80(10):620-8. PubMed ID: 12395146
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Repigmentation of leukoderma in a piebald patient associated with a novel c-KIT gene mutation, G592E, of the tyrosine kinase domain.
    Arase N; Wataya-Kaneda M; Oiso N; Tanemura A; Kawada A; Suzuki T; Katayama I
    J Dermatol Sci; 2011 Nov; 64(2):147-9. PubMed ID: 21925843
    [No Abstract]   [Full Text] [Related]  

  • 66. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autosomal albino chicken mutation (ca/ca) deletes hexanucleotide (-deltaGACTGG817) at a copper-binding site of the tyrosinase gene.
    Tobita-Teramoto T; Jang GY; Kino K; Salter DW; Brumbaugh J; Akiyama T
    Poult Sci; 2000 Jan; 79(1):46-50. PubMed ID: 10685888
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validation of oligonucleotide-mediated gene editing.
    Disterer P; Simons JP; Owen JS
    Gene Ther; 2009 Jun; 16(6):824-6. PubMed ID: 19340016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular characterization of piebaldism in a Tunisian family.
    Kerkeni E; Boubaker S; Sfar S; Bizid M; Besbes H; Bouaziz S; Ghedira N; Amara A; Manoubi W; Gribaa M; Monastiri K
    Pathol Biol (Paris); 2015 Jun; 63(3):113-6. PubMed ID: 25910686
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel KIT gene missense mutation in a Japanese family with piebaldism.
    Nomura K; Hatayama I; Narita T; Kaneko T; Shiraishi M
    J Invest Dermatol; 1998 Aug; 111(2):337-8. PubMed ID: 9699740
    [No Abstract]   [Full Text] [Related]  

  • 71. Piebaldism.
    Oiso N; Fukai K; Kawada A; Suzuki T
    J Dermatol; 2013 May; 40(5):330-5. PubMed ID: 22670867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Piebald trait: implication of kit mutation on in vitro melanocyte survival and on the clinical application of cultured epidermal autografts.
    Bondanza S; Bellini M; Roversi G; Raskovic D; Maurelli R; Paionni E; Paterna P; Dellambra E; Larizza L; Guerra L
    J Invest Dermatol; 2007 Mar; 127(3):676-86. PubMed ID: 17124503
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting (W).
    Spritz RA; Ho L; Strunk KM
    J Invest Dermatol; 1994 Aug; 103(2):148-50. PubMed ID: 7518854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular characterization of two novel KIT mutations in patients with piebaldism.
    Wasag B; Chmara M; Legius E
    J Dermatol Sci; 2012 Apr; 66(1):78-9. PubMed ID: 22264755
    [No Abstract]   [Full Text] [Related]  

  • 75. Two children with a mild or moderate piebaldism phenotype and a father without leukoderma in a family with the same recurrent missense mutation in the kinase domain of KIT.
    Narita T; Oiso N; Fukai K; Motokawa T; Hayashi M; Yokoyama K; Hozumi Y; Kawada A; Suzuki T
    Eur J Dermatol; 2011; 21(3):446-7. PubMed ID: 21680281
    [No Abstract]   [Full Text] [Related]  

  • 76. Genetic disorders of pigmentation.
    Spritz RA; Hearing VJ
    Adv Hum Genet; 1994; 22():1-45. PubMed ID: 7539206
    [No Abstract]   [Full Text] [Related]  

  • 77. [Gene-directed biologically active substances (antisense oligonucleotides and their derivatives)].
    Knorre DG
    Bioorg Khim; 1997 Jan; 23(1):3-17. PubMed ID: 9139640
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Higher efficiency of thymine-adenine clamp-modified single-stranded oligonucleotides in targeted nucleotide sequence correction is not correlated with lower intracellular degradation.
    Wuepping M; Kenner O; Hegele H; Schwandt S; Kaufmann D
    Hum Gene Ther; 2009 Mar; 20(3):283-7. PubMed ID: 19061415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The 'biased' evolution of targeted gene repair.
    Brachman EE; Kmiec EB
    Curr Opin Mol Ther; 2002 Apr; 4(2):171-6. PubMed ID: 12044039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Three novel mutations of the proto-oncogene KIT cause human piebaldism.
    Syrris P; Malik NM; Murday VA; Patton MA; Carter ND; Hughes HE; Metcalfe K
    Am J Med Genet; 2000 Nov; 95(1):79-81. PubMed ID: 11074500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.